Henry Schein (NASDAQ:HSIC) reported quarterly earnings of $1.30 per share which beat the analyst consensus estimate of $1.19 by 9.24 percent. This is a 4.84 percent increase over earnings of $1.24 per share from the same period last year. The company reported quarterly sales of $3.20 billion which beat the analyst consensus estimate of $3.13 billion by 2.24 percent. This is a 9.40 percent increase over sales of $2.92 billion the same period last year.
Morgan Stanley Maintains Overweight on Sophia Genetics, Lowers Price Target to $18
Morgan Stanley maintains Sophia Genetics (NASDAQ:SOPH) with a Overweight and lowers the price target from $23 to $18.
